Synthix Global Pharma Solutions Limited - Company Profile

It is a business services public limited company based in Thane, Maharashtra, India, established in 2025.
2025 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Synthix Global Pharma Solutions Limited

Synthix Global Pharma Solutions Limited, a active public limited company, was established on 29 April 2025 in Thane, Maharashtra, India. it holds CIN: U21001MH2025PLC447046. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Formerly known as Synthix Global Pharma Solutions Limited. Its leadership includes Ramakrishnan Rajagopal (Director), Manish Gupta (Director), Kausalya Santhanam (Director). Past directors included Mohan Muthunarayanan, Swaminathan Ramesh, Venkatramani Raghavan. It is based at Cyber One, Unit No. 902, Sector 30A, Plot No. 4 & 6, Vashi, Navi Mumbai, Thane, Maharashtra, 400703.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001MH2025PLC447046

  • Registration Number

    447046

  • Incorporation Date

    29 April 2025

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Months 30 Days
Company report

Synthix Global Pharma Solutions Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Synthix Global Pharma Solutions Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synthix Global Pharma Solutions Limited?
Current Directors
Name Designation Appointment Date Status
Ramakrishnan Rajagopal Director 29 Apr 2025 Current
Manish Gupta Director 29 Apr 2025 Current
Kausalya Santhanam Director 29 Apr 2025 Current
Sarat Kumar Asuri Additional Director 28 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd - - Past
Pramod Abcsdd Individual Subscriber - Past
Pramod Abcsdd Individual Subscriber - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synthix Global Pharma Solutions.
Synthix Global Pharma Solutions revenue growth over time
Synthix Global Pharma Solutions profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synthix Global Pharma Solutions?

Unlock access to Synthix Global Pharma Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Synthix Global Pharma Solutions?

Unlock and access historical data on people associated with Synthix Global Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synthix Global Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthix Global Pharma Solutions's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synthix Global Pharma Solutions
Recent Activity within the Organization
  • Director Appointment

    The activity Sarat Kumar Asuri was appointed as a Additional Director was appointed as a Additional Director on 28 May 2025 & has been associated with this company since 9 months 1 day . was completed.

  • Director Appointment

    Progress on Ramakrishnan Rajagopal was appointed as a Director was appointed as a Director on 29 Apr 2025 & has been associated with this company since 9 months 30 days . was documented.

  • Director Appointment

    The activity Manish Gupta was appointed as a Director was appointed as a Director on 29 Apr 2025 & has been associated with this company since 9 months 30 days . was completed.

  • Director Appointment

    Progress on Kausalya Santhanam was appointed as a Director was appointed as a Director on 29 Apr 2025 & has been associated with this company since 9 months 30 days . was documented.

  • Company Incorporation

    Synthix Global Pharma Solutions Limited was registered on 29 Apr 2025 with Roc Mumbai & aged 9 months 30 days as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synthix Global Pharma Solutions Limited?

The CIN of Synthix Global Pharma Solutions Limited is U21001MH2025PLC447046.

Where is Synthix Global Pharma Solutions Limited headquartered?

Synthix Global Pharma Solutions Limited is headquartered at Cyber One, Unit No. 902, Sector 30A, Plot No. 4 & 6, Vashi, Navi Mumbai, Thane, Maharashtra, 400703.

When was Synthix Global Pharma Solutions Limited incorporated?

Synthix Global Pharma Solutions Limited was incorporated on 29 April 2025.

Who are the current directors of Synthix Global Pharma Solutions Limited?

The current directors of Synthix Global Pharma Solutions Limited are

Is Synthix Global Pharma Solutions Limited a listed company?

Synthix Global Pharma Solutions Limited is unlisted.

What is the capital structure of Synthix Global Pharma Solutions Limited?

The authorized capital of Synthix Global Pharma Solutions Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available